Format

Send to

Choose Destination
Hum Gene Ther. 1995 May;6(5):643-66.

A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.

Author information

1
Rockefeller University Hospital, New York, New York 10021, USA.
PMID:
7578401
DOI:
10.1089/hum.1995.6.5-643
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center